Shivalik Rasayan Limited
NSE: SHIVALIK · Pesticides & Agrochemicals · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 29 companies in Pesticides & Agrochemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹34 cr vs borrowings ₹114 cr (FY26): borrowings are higher by ₹79 cr.
- Borrowings rose in each of the last 3 years (₹58 cr → ₹114 cr).
- Operating profit covered interest 3.5x in the last 12 months.
- Promoter holding fell by 0.83 percentage points in a year, to 46.54% (2026-09-30).
- Operating cash flow was below net profit in 5 of the last 5 years (FY26, FY25, FY24, FY23, FY22).
- Revenue was higher than a year earlier in 3 of the last 4 quarters.
- Other income was 33% of net profit in the last 12 months.
- Dividend paid in 4 of the last 5 financial years.
- Price ₹313.55 on 2026-10-26: -33.4% from the 52-week high, +51.9% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 82 | 85 | 69 | 89 | 94 | 82 | 103 | 96 |
| EBITDA | 12 | 13 | 6 | 11 | 12 | 10 | 12 | 11 |
| OPM % | 14.3% | 15.6% | 8.3% | 12.3% | 12.8% | 12.6% | 12.1% | 11.6% |
| Other income | 0 | 2 | 6 | 1 | 0 | 1 | 2 | 1 |
| Net profit | 4 | 7 | 4 | 2 | 3 | 3 | 5 | 3 |
| EPS (₹) | 2.58 | 3.39 | 2.62 | 1.02 | 1.93 | 1.71 | 2.87 | 2.16 |
| Revenue YoY | +13.8% | -3.8% | +48.2% | +7.9% | ||||
| Profit YoY | -23.9% | -61.1% | +9.7% | +112.5% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 215 | 234 | 273 | 312 | 368 | 375 |
| EBITDA | 47 | 43 | 39 | 40 | 46 | 46 |
| Net profit | 34 | 30 | 16 | 17 | 12 | 14 |
| EPS (₹) | 18.12 | 15.02 | 10.75 | 10.60 | 7.71 | 8.67 |
| Revenue growth | +9.2% | +16.4% | +14.2% | +18.0% | +14.9% | |
| Profit growth | -12.9% | -45.2% | +2.0% | -27.3% | -18.0% | |
| Dividend / share (₹) | – | 0.50 | 0.50 | 0.50 | 0.50 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +16.2% | – | +14.9% |
| Net profit | -25.9% | – | -18.0% |
| EPS | -19.9% | – | – |
| Share price | – | -24.6% (2y) | -25.6% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 360 | 508 | 536 | 599 |
| Borrowings | – | 58 | 76 | 94 | 114 |
| Cash & equivalents | – | 31 | 38 | 28 | 34 |
| Total assets | – | 578 | 692 | 734 | 819 |
| Fixed assets | – | 217 | 213 | 336 | 334 |
| Capital work in progress | – | 57 | 117 | – | – |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 85 | 87 | 96 | 115 |
| Inventory | – | 75 | 102 | 118 | 147 |
| Payables | – | 66 | 52 | 66 | 80 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 10 | -19 | -6 | -8 | -34 |
| Cash from investing | -23 | -71 | -86 | -13 | -21 |
| Cash from financing | 79 | 50 | 99 | 10 | 62 |
| Capex | 25 | 63 | 79 | 21 | 23 |
| Free cash flow | -15 | -82 | -86 | -28 | -57 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 8.3% | 3.2% | 3.1% | 2.0% |
| ROCE % | – | 8.6% | 5.3% | 5.2% | 4.4% |
| Debtor days | – | 132 | 116 | 113 | 114 |
| Inventory days | – | 239 | 266 | 268 | 285 |
| Payable days | – | 209 | 136 | 151 | 155 |
| Cash conversion cycle (days) | – | 162 | 246 | 230 | 244 |
| Working capital days | – | 184 | 181 | 163 | 190 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 46.54% |
| FIIs | 0.72% |
| DIIs | 0.01% |
| Public (non-institutions) | 52.73% |
| Quarter | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 47.37% | 47.37% | 47.37% | 47.37% | 47.37% | 47.37% | 46.54% | 46.54% |
| Promoter group | % |
|---|---|
| Growel Remedies Limited | 46.54% |
| Public holders above 1% | % |
|---|---|
| Ginnerup Capital ApS | 3.16% |
| Eric Aarestrup Sorensen | 2.09% |
15,231 shareholders. Pledged: – of promoter shares.
Peers in Pesticides & Agrochemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| UPL | ₹42,056 cr | 20.6x | 1.2x | 6.3% | 11.9% | 17.8% | -1.1% | 1.16% |
| PIIND | ₹30,704 cr | 26.3x | 2.7x | 10.5% | 13.3% | 25.3% | +1.1% | 0.74% |
| SUMICHEM | ₹17,685 cr | 30.5x | 5.2x | 18.4% | 23.1% | 21.4% | -2.7% | 0.33% |
| BAYERCROP | ₹15,009 cr | 20.5x | 5.1x | 25.2% | 31.7% | 16.0% | +3.4% | 3.75% |
| SHARDACROP | ₹5,688 cr | 9.1x | 1.8x | 22.2% | 25.8% | 19.5% | +9.2% | 1.91% |
| DHANUKA | ₹3,709 cr | 14.0x | 2.2x | 17.4% | 21.1% | 19.2% | +5.9% | 0.25% |
| RALLIS | ₹3,664 cr | 19.1x | 1.7x | 9.3% | 12.4% | 11.9% | -0.8% | 1.34% |
| NACLIND | ₹2,650 cr | 221.7x | 3.9x | 2.2% | 6.0% | 5.8% | -9.2% | – |
| BHAGCHEM | ₹2,512 cr | 91.4x | 3.6x | 4.0% | 6.1% | 13.0% | +2.2% | 0.07% |
| SHIVALIK | ₹494 cr | 36.2x | 0.8x | 2.4% | 4.5% | 12.3% | +16.2% | 0.44% |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Pharma Formulation | ₹198 cr | 53.7% | ₹16 cr | 7.8% |
| Agrochemicals | ₹151 cr | 41.1% | ₹22 cr | 14.6% |
| Unallacated other operating revenue | ₹10 cr | 2.7% | ₹0 cr | 0.0% |
| Active Pharma Ingredient (API) | ₹9 cr | 2.5% | ₹-6 cr | -71.0% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-09-21 | Dividend | Dividend - Re 0.50 Per Share |
| 2025-09-19 | Dividend | Dividend - Re 0.50 Per Share |
| 2024-09-20 | Dividend | Annual General Meeting/Dividend - Re 0.50 Per Share |
| 2023-09-22 | Dividend | Annual General Meeting/Dividend - Re 0.50 Per Share |
| 2022-09-21 | Dividend | Annual General Meeting/Dividend - Re 0.50 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Manufacturing: Agrochemicals
- Manufacturing: Pharma API
- Research & Development: R & D
| Sector | Commodities |
| Industry | Pesticides & Agrochemicals |
| Sub-industry | Pesticides & Agrochemicals |
| Symbol | SHIVALIK |
| BSE code | 539148 |
| ISIN | INE788J01021 |
| Face value | ₹5.0 |
| Incorporated | 1979-03-16 |
| Website | www.shivalikrasayan.com |
| Plants (India / abroad) | 3 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.